Results 341 to 350 of about 399,504 (355)
Some of the next articles are maybe not open access.

Identification of 4-(2-furanyl)pyrimidin-2-amines as Janus kinase 2 inhibitors

Bioorganic & Medicinal Chemistry, 2017
Janus kinases inhibitor is considered to have therapeutic potential for the treatment of oncology and immune-inflammatory diseases. Two series of 4-(2-benzofuranyl)pyrimidin-2-amine and 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl)pyrimidin-2-amine derivatives have been designed and synthesized.
Yazhou, Wang   +8 more
openaire   +2 more sources

Inhibition of Janus kinase 2 by cyclometalated rhodium complexes

MedChemComm, 2012
Cyclometalated rhodium complexes were synthesized and evaluated as JAK2 metal-based inhibitors. Complexes 1 and 2 inhibited JAK2 enzyme phosphorylation activity, reduced JAK2 autophosphorylation in cellulo and exhibited cytotoxicity towards HEL cancer cells. To our knowledge, these are the first two examples of metal-based inhibitors of JAK2.
Chung-Hang Leung   +7 more
openaire   +1 more source

Successful therapy for pyoderma gangrenosum with a Janus kinase 2 inhibitor

British Journal of Dermatology, 2018
S. Nasifoglu, B. Heinrich, J. Welzel
semanticscholar   +1 more source

CircScd1 Promotes Fatty Liver Disease via the Janus Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway

Digestive Diseases and Sciences, 2018
Peifei Li   +5 more
semanticscholar   +1 more source

Janus kinase-2 mutation, cirrhosis and splanchnic vein thrombosis

European Journal of Gastroenterology & Hepatology, 2008
COLAIZZO D   +4 more
openaire   +2 more sources

The Development and Use of Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms.

Hematology/Oncology Clinics of North America, 2017
G. Hobbs, Sarah S. Rozelle, A. Mullally
semanticscholar   +1 more source

Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis

Gut, 2015
S. Klein   +15 more
semanticscholar   +1 more source

Putamina Involvement in Wernicke Encephalopathy Induced by Janus Kinase 2 Inhibitor

Clinical neuropharmacology, 2015
Jorge Rodríguez-Pardo   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy